Structured Review

Addgene inc expression vector pegfp c1
Expression Vector Pegfp C1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/expression vector pegfp c1/product/Addgene inc
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
expression vector pegfp c1 - by Bioz Stars, 2024-10
95/100 stars

Images


Structured Review

Addgene inc pegfp c1
Pegfp C1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pegfp c1/product/Addgene inc
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
pegfp c1 - by Bioz Stars, 2024-10
95/100 stars

Images


Structured Review

Santa Cruz Biotechnology nf κb p65
Representative photographs of monolayer differentiated cells (Days 2 and 7: original magnification, x200) (A). Representative electrophoretic mobility shift assays (EMSA) <t>shows</t> <t>NF-κB</t> binding activity in the undifferentiated iPS cells (FGF2+ and feeder+) and monolayer differentiated cells (FGF2- and feeder-). Proximal tubular epithelial cells (PTECs) were used as control cells (differentiated cells) for the EMSA. Results of 2 independent experiments are shown. In the last lane, the competition assays were performed using the undifferentiated iPS cells (B). Western blot analysis of actin, Oct3/4, NANOG, WT-1, and Pax-2 in the undifferentiated iPS cells (FGF2+ and feeder+) and monolayer differentiated cells (FGF2- and feeder-). Feeder cells (SNL) were used as negative control cells. Results of 2 independent experiments are shown (C).
Nf κb P65, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nf κb p65/product/Santa Cruz Biotechnology
Average 94 stars, based on 1 article reviews
Price from $9.99 to $1999.99
nf κb p65 - by Bioz Stars, 2024-10
94/100 stars

Images

1) Product Images from "The Role of NF-κB Signaling in the Maintenance of Pluripotency of Human Induced Pluripotent Stem Cells"

Article Title: The Role of NF-κB Signaling in the Maintenance of Pluripotency of Human Induced Pluripotent Stem Cells

Journal: PLoS ONE

doi: 10.1371/journal.pone.0056399

Representative photographs of monolayer differentiated cells (Days 2 and 7: original magnification, x200) (A). Representative electrophoretic mobility shift assays (EMSA) shows NF-κB binding activity in the undifferentiated iPS cells (FGF2+ and feeder+) and monolayer differentiated cells (FGF2- and feeder-). Proximal tubular epithelial cells (PTECs) were used as control cells (differentiated cells) for the EMSA. Results of 2 independent experiments are shown. In the last lane, the competition assays were performed using the undifferentiated iPS cells (B). Western blot analysis of actin, Oct3/4, NANOG, WT-1, and Pax-2 in the undifferentiated iPS cells (FGF2+ and feeder+) and monolayer differentiated cells (FGF2- and feeder-). Feeder cells (SNL) were used as negative control cells. Results of 2 independent experiments are shown (C).
Figure Legend Snippet: Representative photographs of monolayer differentiated cells (Days 2 and 7: original magnification, x200) (A). Representative electrophoretic mobility shift assays (EMSA) shows NF-κB binding activity in the undifferentiated iPS cells (FGF2+ and feeder+) and monolayer differentiated cells (FGF2- and feeder-). Proximal tubular epithelial cells (PTECs) were used as control cells (differentiated cells) for the EMSA. Results of 2 independent experiments are shown. In the last lane, the competition assays were performed using the undifferentiated iPS cells (B). Western blot analysis of actin, Oct3/4, NANOG, WT-1, and Pax-2 in the undifferentiated iPS cells (FGF2+ and feeder+) and monolayer differentiated cells (FGF2- and feeder-). Feeder cells (SNL) were used as negative control cells. Results of 2 independent experiments are shown (C).

Techniques Used: Electrophoretic Mobility Shift Assay, Binding Assay, Activity Assay, Western Blot, Negative Control

Representative photomicrographs of human iPS cells: no treatment (A–D), treatment with control siRNA (E–H), treatment wirth p65 siRNA (I–L) (original magnification, x200). A representative EMSA shows NF-κB and AP-1 binding activity in human iPS cells treated with siRNA (M). Representative photographs of alkaline phosphatase staining of human iPS cells treated with siRNA (N–P) (original magnification, x200). No treatment (N), treatment with control siRNA (O), treatment with p65 siRNA (P).
Figure Legend Snippet: Representative photomicrographs of human iPS cells: no treatment (A–D), treatment with control siRNA (E–H), treatment wirth p65 siRNA (I–L) (original magnification, x200). A representative EMSA shows NF-κB and AP-1 binding activity in human iPS cells treated with siRNA (M). Representative photographs of alkaline phosphatase staining of human iPS cells treated with siRNA (N–P) (original magnification, x200). No treatment (N), treatment with control siRNA (O), treatment with p65 siRNA (P).

Techniques Used: Binding Assay, Activity Assay, Staining

Western blot analysis of actin, NF-κB p65, IκBα, Oct3/4, Nanog, WT-1, and Pax-2 in human iPS cells treated with siRNA (A). Immunohistochemical staining for NF-κB p65 (B–D) and Oct3/4 (E–G) in human iPS cells treated with siRNA. No treatment (B and E), treatment with control siRNA (C and F), and treatment with p65 siRNA (D and G). Negative control staining without a primary antibody is shown (H) (Original magnification, x200).
Figure Legend Snippet: Western blot analysis of actin, NF-κB p65, IκBα, Oct3/4, Nanog, WT-1, and Pax-2 in human iPS cells treated with siRNA (A). Immunohistochemical staining for NF-κB p65 (B–D) and Oct3/4 (E–G) in human iPS cells treated with siRNA. No treatment (B and E), treatment with control siRNA (C and F), and treatment with p65 siRNA (D and G). Negative control staining without a primary antibody is shown (H) (Original magnification, x200).

Techniques Used: Western Blot, Immunohistochemical staining, Staining, Negative Control


Structured Review

Santa Cruz Biotechnology sirna against nf κb p65
Effects of TPL and ATF <t>on</t> <t>NF-κB</t> and JNK signalling pathway. ( A ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. Nuclear proteins were extracted and subjected to Western blotting for <t>p65</t> detection. Lamin B was used as loading control and α-tubulin was used as a cytoplasmic protein marker to rule out cytoplasmic contamination in the nuclear fraction. ( B ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. AKT, p-AKT, and c-FLIP proteins in whole cell lysates were determined with specific antibodies. GAPDH was used as loading control. ( C ) HCT116 cells were transfected with scramble <t>siRNA</t> or NF-κB p65 siRNA. 48 h later, cell extracts were applied for Western blotting analysis using NF-κB p65 and c-FLIP antibodies. ( D ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. c-JUN, p-c-JUN and p-JNK protein in whole cell lysates were determined with specific antibodies.
Sirna Against Nf κb P65, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirna against nf κb p65/product/Santa Cruz Biotechnology
Average 94 stars, based on 1 article reviews
Price from $9.99 to $1999.99
sirna against nf κb p65 - by Bioz Stars, 2024-10
94/100 stars

Images

1) Product Images from "Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase"

Article Title: Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase

Journal: Molecular Cancer

doi: 10.1186/1476-4598-12-54

Effects of TPL and ATF on NF-κB and JNK signalling pathway. ( A ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. Nuclear proteins were extracted and subjected to Western blotting for p65 detection. Lamin B was used as loading control and α-tubulin was used as a cytoplasmic protein marker to rule out cytoplasmic contamination in the nuclear fraction. ( B ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. AKT, p-AKT, and c-FLIP proteins in whole cell lysates were determined with specific antibodies. GAPDH was used as loading control. ( C ) HCT116 cells were transfected with scramble siRNA or NF-κB p65 siRNA. 48 h later, cell extracts were applied for Western blotting analysis using NF-κB p65 and c-FLIP antibodies. ( D ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. c-JUN, p-c-JUN and p-JNK protein in whole cell lysates were determined with specific antibodies.
Figure Legend Snippet: Effects of TPL and ATF on NF-κB and JNK signalling pathway. ( A ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. Nuclear proteins were extracted and subjected to Western blotting for p65 detection. Lamin B was used as loading control and α-tubulin was used as a cytoplasmic protein marker to rule out cytoplasmic contamination in the nuclear fraction. ( B ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. AKT, p-AKT, and c-FLIP proteins in whole cell lysates were determined with specific antibodies. GAPDH was used as loading control. ( C ) HCT116 cells were transfected with scramble siRNA or NF-κB p65 siRNA. 48 h later, cell extracts were applied for Western blotting analysis using NF-κB p65 and c-FLIP antibodies. ( D ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. c-JUN, p-c-JUN and p-JNK protein in whole cell lysates were determined with specific antibodies.

Techniques Used: Western Blot, Marker, Transfection

A working model for the synergistic effect of TPL and ATF on tumour cells. TPL and ATF cooperatively induce apoptosis through caspase-dependent pathway and cell cycle arrest. In HCT116 cells, combined treatment with TPL and ATF at a low dosage inhibits AKT phosphorylation and subsequently inactivates NF-κB. The inhibition of NF-κB leads to down-regulation of c-FLIP, activation of caspases-9/caspase-3 and JNK-c-JUN pathway, and cell cycle arrest, which finally promotes cell apoptosis. In addition, the suppression of NF-κB leads to decreased expression of uPAR, MMP-9 and phospho-FAK, thereby inhibiting tumor cell migration and invasion. Furthermore, ATF can segregate uPA from its receptor uPAR, thus blocking ECM remodeling and anti-angiogenesis processes.
Figure Legend Snippet: A working model for the synergistic effect of TPL and ATF on tumour cells. TPL and ATF cooperatively induce apoptosis through caspase-dependent pathway and cell cycle arrest. In HCT116 cells, combined treatment with TPL and ATF at a low dosage inhibits AKT phosphorylation and subsequently inactivates NF-κB. The inhibition of NF-κB leads to down-regulation of c-FLIP, activation of caspases-9/caspase-3 and JNK-c-JUN pathway, and cell cycle arrest, which finally promotes cell apoptosis. In addition, the suppression of NF-κB leads to decreased expression of uPAR, MMP-9 and phospho-FAK, thereby inhibiting tumor cell migration and invasion. Furthermore, ATF can segregate uPA from its receptor uPAR, thus blocking ECM remodeling and anti-angiogenesis processes.

Techniques Used: Inhibition, Activation Assay, Expressing, Migration, Blocking Assay


Structured Review

Santa Cruz Biotechnology nf κb p65
Serum-starved HASMCs were pretreated with NAC (2.5 mmol/L) and DPI (10 µmol/L) for 30 min before incubation with IS (250 µmol/L) for 24 h (A,B). HASMCs were transfected with or without OAT3 siRNA (10 nmol/L), AhR siRNA (30 nmol/L) or <t>p65</t> siRNA (10 nmol/L), and serum starved for 24 h, followed by incubation with IS (250 µmol/L) for 24 h. Cell lysates were immunoblotted using anti-OAT3, anti-AhR, anti-p65 and anti-PRR antibodies ( C–F ). Mean±SE (n = 3). *p<0.05 vs control, #p<0.05 vs IS-treated group. Ctrl: control.
Nf κb P65, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nf κb p65/product/Santa Cruz Biotechnology
Average 94 stars, based on 1 article reviews
Price from $9.99 to $1999.99
nf κb p65 - by Bioz Stars, 2024-10
94/100 stars

Images

1) Product Images from "Indoxyl Sulfate-Induced Activation of (Pro)renin Receptor Promotes Cell Proliferation and Tissue Factor Expression in Vascular Smooth Muscle Cells"

Article Title: Indoxyl Sulfate-Induced Activation of (Pro)renin Receptor Promotes Cell Proliferation and Tissue Factor Expression in Vascular Smooth Muscle Cells

Journal: PLoS ONE

doi: 10.1371/journal.pone.0109268

Serum-starved HASMCs were pretreated with NAC (2.5 mmol/L) and DPI (10 µmol/L) for 30 min before incubation with IS (250 µmol/L) for 24 h (A,B). HASMCs were transfected with or without OAT3 siRNA (10 nmol/L), AhR siRNA (30 nmol/L) or p65 siRNA (10 nmol/L), and serum starved for 24 h, followed by incubation with IS (250 µmol/L) for 24 h. Cell lysates were immunoblotted using anti-OAT3, anti-AhR, anti-p65 and anti-PRR antibodies ( C–F ). Mean±SE (n = 3). *p<0.05 vs control, #p<0.05 vs IS-treated group. Ctrl: control.
Figure Legend Snippet: Serum-starved HASMCs were pretreated with NAC (2.5 mmol/L) and DPI (10 µmol/L) for 30 min before incubation with IS (250 µmol/L) for 24 h (A,B). HASMCs were transfected with or without OAT3 siRNA (10 nmol/L), AhR siRNA (30 nmol/L) or p65 siRNA (10 nmol/L), and serum starved for 24 h, followed by incubation with IS (250 µmol/L) for 24 h. Cell lysates were immunoblotted using anti-OAT3, anti-AhR, anti-p65 and anti-PRR antibodies ( C–F ). Mean±SE (n = 3). *p<0.05 vs control, #p<0.05 vs IS-treated group. Ctrl: control.

Techniques Used: Incubation, Transfection

Serum starved HASMCs were pretreated with NAC (2.5 mmol/L) and DPI (10 µmol/L) for 30 min before incubation with IS (250 µmol/L) for 24 h ( A, B ). HASMCs were transfected with or without OAT3 siRNA (10 nmol/L), AhR siRNA (30 nmol/L) or p65 siRNA (10 nmol/L), and serum starved for 24 h, followed by incubation with IS (250 µmol/L) for 24 h. Cell lysates were immunoblotted using anti-OAT3, anti-AhR, anti-p65 and anti-prorenin antibodies ( C–F ). Mean±SE (n = 3). *p<0.05, **p<0.01 vs untreated group, #p<0.01 vs IS-treated group. Ctrl: control.
Figure Legend Snippet: Serum starved HASMCs were pretreated with NAC (2.5 mmol/L) and DPI (10 µmol/L) for 30 min before incubation with IS (250 µmol/L) for 24 h ( A, B ). HASMCs were transfected with or without OAT3 siRNA (10 nmol/L), AhR siRNA (30 nmol/L) or p65 siRNA (10 nmol/L), and serum starved for 24 h, followed by incubation with IS (250 µmol/L) for 24 h. Cell lysates were immunoblotted using anti-OAT3, anti-AhR, anti-p65 and anti-prorenin antibodies ( C–F ). Mean±SE (n = 3). *p<0.05, **p<0.01 vs untreated group, #p<0.01 vs IS-treated group. Ctrl: control.

Techniques Used: Incubation, Transfection


Structured Review

Santa Cruz Biotechnology sc 29410 p65
Sc 29410 P65, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sc 29410 p65/product/Santa Cruz Biotechnology
Average 94 stars, based on 1 article reviews
Price from $9.99 to $1999.99
sc 29410 p65 - by Bioz Stars, 2024-10
94/100 stars

Images


Structured Review

Addgene inc pegfp c1
Pegfp C1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pegfp c1/product/Addgene inc
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
pegfp c1 - by Bioz Stars, 2024-10
95/100 stars

Images


Structured Review

Santa Cruz Biotechnology nf κ b p65 shrna
Increased expression of SNHG14 in LPS-induced HK-2 cells is due to the activation of the TLR4/NF- <t>κ</t> <t>B</t> pathway. (a) Expression level of SNHG14 in LPS-treated HK-2 cells. (b) Predicted binding site of NF- κ B in the SHNG14 promoter. (c) Activation of the TLR4/NF- κ B pathway in LPS-induced HK-2 cells. (d) ChIP assay showed NF- κ B bound to the SNHG14 promoter. (e) Luciferase assays showed that overexpressing NF- κ B <t>p65</t> increased the activity of luciferase reporter containing a wild-type SNHG14 promoter. (f) SNHG14 levels in LPS-induced HK-2 cells transfected with NF- κ B p65 overexpression plasmids or shRNAs. Data were shown as mean ± SD, ∗ P < 0.05.
Nf κ B P65 Shrna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nf κ b p65 shrna/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
nf κ b p65 shrna - by Bioz Stars, 2024-10
93/100 stars

Images

1) Product Images from "lncRNA SNHG14 Plays a Role in Sepsis-Induced Acute Kidney Injury by Regulating miR-93"

Article Title: lncRNA SNHG14 Plays a Role in Sepsis-Induced Acute Kidney Injury by Regulating miR-93

Journal: Mediators of Inflammation

doi: 10.1155/2021/5318369

Increased expression of SNHG14 in LPS-induced HK-2 cells is due to the activation of the TLR4/NF- κ B pathway. (a) Expression level of SNHG14 in LPS-treated HK-2 cells. (b) Predicted binding site of NF- κ B in the SHNG14 promoter. (c) Activation of the TLR4/NF- κ B pathway in LPS-induced HK-2 cells. (d) ChIP assay showed NF- κ B bound to the SNHG14 promoter. (e) Luciferase assays showed that overexpressing NF- κ B p65 increased the activity of luciferase reporter containing a wild-type SNHG14 promoter. (f) SNHG14 levels in LPS-induced HK-2 cells transfected with NF- κ B p65 overexpression plasmids or shRNAs. Data were shown as mean ± SD, ∗ P < 0.05.
Figure Legend Snippet: Increased expression of SNHG14 in LPS-induced HK-2 cells is due to the activation of the TLR4/NF- κ B pathway. (a) Expression level of SNHG14 in LPS-treated HK-2 cells. (b) Predicted binding site of NF- κ B in the SHNG14 promoter. (c) Activation of the TLR4/NF- κ B pathway in LPS-induced HK-2 cells. (d) ChIP assay showed NF- κ B bound to the SNHG14 promoter. (e) Luciferase assays showed that overexpressing NF- κ B p65 increased the activity of luciferase reporter containing a wild-type SNHG14 promoter. (f) SNHG14 levels in LPS-induced HK-2 cells transfected with NF- κ B p65 overexpression plasmids or shRNAs. Data were shown as mean ± SD, ∗ P < 0.05.

Techniques Used: Expressing, Activation Assay, Binding Assay, Luciferase, Activity Assay, Transfection, Over Expression

SNHG14/miR-93 activates NF- κ B and STAT3 signaling through mediating IRAK4 and IL-6R. (a) Predicted binding site of miR-93 in IRAK4 and IL-6R 3′UTR. (b, c) Luciferase assays showed that overexpressing miR-93 decreased the activity of luciferase reporter containing wild-type IRAK4 or IL-6R 3′UTR. (d) IRAK4 and IL-6R protein levels detected by western blot after HK-2 cells were transfected with miR-93 mimics or inhibitor. (e, f) HK-2 cells were transfected with SNHG14 overexpression plasmids and miR-93 mimics, and LPS-induced HK-2 cells were transfected with SNHG14 shRNAs and miR-93 inhibitor; relative proteins in IRAK4/NF-kb and IL-6R/STAT3 signaling were analyzed using western blot. Data were shown as mean ± SD, ∗ P < 0.05.
Figure Legend Snippet: SNHG14/miR-93 activates NF- κ B and STAT3 signaling through mediating IRAK4 and IL-6R. (a) Predicted binding site of miR-93 in IRAK4 and IL-6R 3′UTR. (b, c) Luciferase assays showed that overexpressing miR-93 decreased the activity of luciferase reporter containing wild-type IRAK4 or IL-6R 3′UTR. (d) IRAK4 and IL-6R protein levels detected by western blot after HK-2 cells were transfected with miR-93 mimics or inhibitor. (e, f) HK-2 cells were transfected with SNHG14 overexpression plasmids and miR-93 mimics, and LPS-induced HK-2 cells were transfected with SNHG14 shRNAs and miR-93 inhibitor; relative proteins in IRAK4/NF-kb and IL-6R/STAT3 signaling were analyzed using western blot. Data were shown as mean ± SD, ∗ P < 0.05.

Techniques Used: Binding Assay, Luciferase, Activity Assay, Western Blot, Transfection, Over Expression

Silencing SNHG14 alleviates the cellular injury process of IL-1 β and IL-6 in HK-2 cells via miR-93. (a–n) HK-2 cells were treated with IL-1 β or IL-6 and then transfected with SNHG14 shRNAs and miR-93 inhibitor; oxidative stress (a–d), inflammation (e–h), and apoptosis (i–l) were assessed as described above; activation of NF- κ B and STAT3 signaling was tested by detecting relative proteins using western blot (m, n). Data were shown as mean ± SD, ∗ P < 0.05.
Figure Legend Snippet: Silencing SNHG14 alleviates the cellular injury process of IL-1 β and IL-6 in HK-2 cells via miR-93. (a–n) HK-2 cells were treated with IL-1 β or IL-6 and then transfected with SNHG14 shRNAs and miR-93 inhibitor; oxidative stress (a–d), inflammation (e–h), and apoptosis (i–l) were assessed as described above; activation of NF- κ B and STAT3 signaling was tested by detecting relative proteins using western blot (m, n). Data were shown as mean ± SD, ∗ P < 0.05.

Techniques Used: Transfection, Activation Assay, Western Blot


Structured Review

Santa Cruz Biotechnology nf κb p65 sirna
Effect of TPL <t>on</t> <t>NF-κB</t> activity and NF-κB <t>p65</t> expression inMHCC-97H cell. ( A ) MHCC-97H cells were treated with 5, 15,or 25 μM TPL for 72 hours. Nuclear extracts were prepared from control and treated cells and subjected to analysis for NF-κB DNA-binding activity as measured by EMSA. ( B ) MHCC-97H cells were treated with 25 μM TPL for 24–60 hours. Nuclear extracts were prepared from control and treated cells and subjected to analysis for NF-κB DNA-binding activity as measured by EMSA. ( C ) MHCC-97H cells were treated with 5, 15, or 25 μM TPL for 72 hours. NF-κB p65 protein was detected by western blot assay; ( D ) MHCC-97H cells were treated with 25 μM TPL for 24–60 hours. NF-κB p65 protein was detected by western blot assay.
Nf κb P65 Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nf κb p65 sirna/product/Santa Cruz Biotechnology
Average 94 stars, based on 1 article reviews
Price from $9.99 to $1999.99
nf κb p65 sirna - by Bioz Stars, 2024-10
94/100 stars

Images

1) Product Images from "Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling"

Article Title: Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling

Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

doi: 10.12659/MSM.898801

Effect of TPL on NF-κB activity and NF-κB p65 expression inMHCC-97H cell. ( A ) MHCC-97H cells were treated with 5, 15,or 25 μM TPL for 72 hours. Nuclear extracts were prepared from control and treated cells and subjected to analysis for NF-κB DNA-binding activity as measured by EMSA. ( B ) MHCC-97H cells were treated with 25 μM TPL for 24–60 hours. Nuclear extracts were prepared from control and treated cells and subjected to analysis for NF-κB DNA-binding activity as measured by EMSA. ( C ) MHCC-97H cells were treated with 5, 15, or 25 μM TPL for 72 hours. NF-κB p65 protein was detected by western blot assay; ( D ) MHCC-97H cells were treated with 25 μM TPL for 24–60 hours. NF-κB p65 protein was detected by western blot assay.
Figure Legend Snippet: Effect of TPL on NF-κB activity and NF-κB p65 expression inMHCC-97H cell. ( A ) MHCC-97H cells were treated with 5, 15,or 25 μM TPL for 72 hours. Nuclear extracts were prepared from control and treated cells and subjected to analysis for NF-κB DNA-binding activity as measured by EMSA. ( B ) MHCC-97H cells were treated with 25 μM TPL for 24–60 hours. Nuclear extracts were prepared from control and treated cells and subjected to analysis for NF-κB DNA-binding activity as measured by EMSA. ( C ) MHCC-97H cells were treated with 5, 15, or 25 μM TPL for 72 hours. NF-κB p65 protein was detected by western blot assay; ( D ) MHCC-97H cells were treated with 25 μM TPL for 24–60 hours. NF-κB p65 protein was detected by western blot assay.

Techniques Used: Activity Assay, Expressing, Binding Assay, Western Blot

TPL induces apoptosis by inhibition of NF-κB activity.( A ) The effect of p65 cDNA transfection and TPL treatment on NF-κB DNA-binding activity by EMSA assay. ( B ) Induction of apoptosis by p65 cDNA and TPL in MHCC-97H cells tested by flow cytometry. ( C ) Induction of apoptosis by p65 cDNA and TPL in MHCC-97H cells tested by TUNEL assay. ( D ) the effect of p65 siRNA transfection and TPL on NF-κB DNA-binding activity by EMSA assay. ( E ) Induction of apoptosis by p65 siRNA and TPL in MHCC-97H cells tested by flow cytometry. ( F ) Induction of apoptosis by p65 siRNA and TPL in MHCC-97H cells tested by TUNEL assay. Values are reported as mean ±SD. p <0.05, compared to the control.
Figure Legend Snippet: TPL induces apoptosis by inhibition of NF-κB activity.( A ) The effect of p65 cDNA transfection and TPL treatment on NF-κB DNA-binding activity by EMSA assay. ( B ) Induction of apoptosis by p65 cDNA and TPL in MHCC-97H cells tested by flow cytometry. ( C ) Induction of apoptosis by p65 cDNA and TPL in MHCC-97H cells tested by TUNEL assay. ( D ) the effect of p65 siRNA transfection and TPL on NF-κB DNA-binding activity by EMSA assay. ( E ) Induction of apoptosis by p65 siRNA and TPL in MHCC-97H cells tested by flow cytometry. ( F ) Induction of apoptosis by p65 siRNA and TPL in MHCC-97H cells tested by TUNEL assay. Values are reported as mean ±SD. p <0.05, compared to the control.

Techniques Used: Inhibition, Activity Assay, Transfection, Binding Assay, Flow Cytometry, TUNEL Assay

TPL inhibits tumor growth and the expression of NF-κB target genes in vivo . MHCC-97H xenografts were generated by inoculating cells subcutaneously (s.c.) in SCID mice. Once transplanted, the cells developed into palpable tumors (about 80 mg), and groups of 10 animals were classified randomly and assigned to different treatment groups. Mice were injected with TPL at 0.4 mg/kg daily for 15 days. The control group received vehicle only. ( A ) TPL retards the growth of MHCC-97H tumor xenografts in nude mice. Tumor volumes in SCID mice were plotted against time; * p <0.05, compared to the control. ( B ) The number of metastatic nodes in each group. Lung tumors were counted with the naked eye. The data represent the mean and the standard deviation (n=10). p values were calculated with the Student’s t-test. * p <0.05. Black is a metastatic node. ( C ) TPL inhibits NF-κB DNA-binding activity in vivo . Tumor xenografts were removed, and nuclear protein extracts were prepared. Binding of NF-κB consensus elements with nuclear extracts was detected by EMSA. ( D ) The expression of NF-κB p65 and MMP-9 was detected by western blotting of tumor tissue extracts. TPL inhibited the expression of NF-κB p65 and MMP-9 in tumor tissues of TPL treated animals compared to controls.
Figure Legend Snippet: TPL inhibits tumor growth and the expression of NF-κB target genes in vivo . MHCC-97H xenografts were generated by inoculating cells subcutaneously (s.c.) in SCID mice. Once transplanted, the cells developed into palpable tumors (about 80 mg), and groups of 10 animals were classified randomly and assigned to different treatment groups. Mice were injected with TPL at 0.4 mg/kg daily for 15 days. The control group received vehicle only. ( A ) TPL retards the growth of MHCC-97H tumor xenografts in nude mice. Tumor volumes in SCID mice were plotted against time; * p <0.05, compared to the control. ( B ) The number of metastatic nodes in each group. Lung tumors were counted with the naked eye. The data represent the mean and the standard deviation (n=10). p values were calculated with the Student’s t-test. * p <0.05. Black is a metastatic node. ( C ) TPL inhibits NF-κB DNA-binding activity in vivo . Tumor xenografts were removed, and nuclear protein extracts were prepared. Binding of NF-κB consensus elements with nuclear extracts was detected by EMSA. ( D ) The expression of NF-κB p65 and MMP-9 was detected by western blotting of tumor tissue extracts. TPL inhibited the expression of NF-κB p65 and MMP-9 in tumor tissues of TPL treated animals compared to controls.

Techniques Used: Expressing, In Vivo, Generated, Injection, Standard Deviation, Binding Assay, Activity Assay, Western Blot


Structured Review

Addgene inc pegfp c1 expression vectors
PK-15 cells were transfected with <t>pEGFP-C1-wild-type</t> sPPARD (A), and -G32E mutant (B). G32E mutant was treated by leptomycin B (50 nM, 1 h) that blocked CRM1-dependent nuclear export (C). sPPARD subcellular localization was analyzed by GFP fluorescence at 24 hour post-transfection. Cell nuclei were counterstained with DAPI.
Pegfp C1 Expression Vectors, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pegfp c1 expression vectors/product/Addgene inc
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
pegfp c1 expression vectors - by Bioz Stars, 2024-10
95/100 stars

Images

1) Product Images from "The G32E Functional Variant Reduces Activity of PPARD by Nuclear Export and Post-Translational Modification in Pigs"

Article Title: The G32E Functional Variant Reduces Activity of PPARD by Nuclear Export and Post-Translational Modification in Pigs

Journal: PLoS ONE

doi: 10.1371/journal.pone.0075925

PK-15 cells were transfected with pEGFP-C1-wild-type sPPARD (A), and -G32E mutant (B). G32E mutant was treated by leptomycin B (50 nM, 1 h) that blocked CRM1-dependent nuclear export (C). sPPARD subcellular localization was analyzed by GFP fluorescence at 24 hour post-transfection. Cell nuclei were counterstained with DAPI.
Figure Legend Snippet: PK-15 cells were transfected with pEGFP-C1-wild-type sPPARD (A), and -G32E mutant (B). G32E mutant was treated by leptomycin B (50 nM, 1 h) that blocked CRM1-dependent nuclear export (C). sPPARD subcellular localization was analyzed by GFP fluorescence at 24 hour post-transfection. Cell nuclei were counterstained with DAPI.

Techniques Used: Transfection, Mutagenesis, Fluorescence

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95
    Addgene inc expression vector pegfp c1
    Expression Vector Pegfp C1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/expression vector pegfp c1/product/Addgene inc
    Average 95 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    expression vector pegfp c1 - by Bioz Stars, 2024-10
    95/100 stars
      Buy from Supplier

    95
    Addgene inc pegfp c1
    Pegfp C1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pegfp c1/product/Addgene inc
    Average 95 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pegfp c1 - by Bioz Stars, 2024-10
    95/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology nf κb p65
    Representative photographs of monolayer differentiated cells (Days 2 and 7: original magnification, x200) (A). Representative electrophoretic mobility shift assays (EMSA) <t>shows</t> <t>NF-κB</t> binding activity in the undifferentiated iPS cells (FGF2+ and feeder+) and monolayer differentiated cells (FGF2- and feeder-). Proximal tubular epithelial cells (PTECs) were used as control cells (differentiated cells) for the EMSA. Results of 2 independent experiments are shown. In the last lane, the competition assays were performed using the undifferentiated iPS cells (B). Western blot analysis of actin, Oct3/4, NANOG, WT-1, and Pax-2 in the undifferentiated iPS cells (FGF2+ and feeder+) and monolayer differentiated cells (FGF2- and feeder-). Feeder cells (SNL) were used as negative control cells. Results of 2 independent experiments are shown (C).
    Nf κb P65, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nf κb p65/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    nf κb p65 - by Bioz Stars, 2024-10
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology sirna against nf κb p65
    Effects of TPL and ATF <t>on</t> <t>NF-κB</t> and JNK signalling pathway. ( A ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. Nuclear proteins were extracted and subjected to Western blotting for <t>p65</t> detection. Lamin B was used as loading control and α-tubulin was used as a cytoplasmic protein marker to rule out cytoplasmic contamination in the nuclear fraction. ( B ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. AKT, p-AKT, and c-FLIP proteins in whole cell lysates were determined with specific antibodies. GAPDH was used as loading control. ( C ) HCT116 cells were transfected with scramble <t>siRNA</t> or NF-κB p65 siRNA. 48 h later, cell extracts were applied for Western blotting analysis using NF-κB p65 and c-FLIP antibodies. ( D ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. c-JUN, p-c-JUN and p-JNK protein in whole cell lysates were determined with specific antibodies.
    Sirna Against Nf κb P65, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sirna against nf κb p65/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    sirna against nf κb p65 - by Bioz Stars, 2024-10
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology sc 29410 p65
    Effects of TPL and ATF <t>on</t> <t>NF-κB</t> and JNK signalling pathway. ( A ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. Nuclear proteins were extracted and subjected to Western blotting for <t>p65</t> detection. Lamin B was used as loading control and α-tubulin was used as a cytoplasmic protein marker to rule out cytoplasmic contamination in the nuclear fraction. ( B ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. AKT, p-AKT, and c-FLIP proteins in whole cell lysates were determined with specific antibodies. GAPDH was used as loading control. ( C ) HCT116 cells were transfected with scramble <t>siRNA</t> or NF-κB p65 siRNA. 48 h later, cell extracts were applied for Western blotting analysis using NF-κB p65 and c-FLIP antibodies. ( D ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. c-JUN, p-c-JUN and p-JNK protein in whole cell lysates were determined with specific antibodies.
    Sc 29410 P65, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sc 29410 p65/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    sc 29410 p65 - by Bioz Stars, 2024-10
    94/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology nf κ b p65 shrna
    Increased expression of SNHG14 in LPS-induced HK-2 cells is due to the activation of the TLR4/NF- <t>κ</t> <t>B</t> pathway. (a) Expression level of SNHG14 in LPS-treated HK-2 cells. (b) Predicted binding site of NF- κ B in the SHNG14 promoter. (c) Activation of the TLR4/NF- κ B pathway in LPS-induced HK-2 cells. (d) ChIP assay showed NF- κ B bound to the SNHG14 promoter. (e) Luciferase assays showed that overexpressing NF- κ B <t>p65</t> increased the activity of luciferase reporter containing a wild-type SNHG14 promoter. (f) SNHG14 levels in LPS-induced HK-2 cells transfected with NF- κ B p65 overexpression plasmids or shRNAs. Data were shown as mean ± SD, ∗ P < 0.05.
    Nf κ B P65 Shrna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nf κ b p65 shrna/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    nf κ b p65 shrna - by Bioz Stars, 2024-10
    93/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology nf κb p65 sirna
    Effect of TPL <t>on</t> <t>NF-κB</t> activity and NF-κB <t>p65</t> expression inMHCC-97H cell. ( A ) MHCC-97H cells were treated with 5, 15,or 25 μM TPL for 72 hours. Nuclear extracts were prepared from control and treated cells and subjected to analysis for NF-κB DNA-binding activity as measured by EMSA. ( B ) MHCC-97H cells were treated with 25 μM TPL for 24–60 hours. Nuclear extracts were prepared from control and treated cells and subjected to analysis for NF-κB DNA-binding activity as measured by EMSA. ( C ) MHCC-97H cells were treated with 5, 15, or 25 μM TPL for 72 hours. NF-κB p65 protein was detected by western blot assay; ( D ) MHCC-97H cells were treated with 25 μM TPL for 24–60 hours. NF-κB p65 protein was detected by western blot assay.
    Nf κb P65 Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nf κb p65 sirna/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    nf κb p65 sirna - by Bioz Stars, 2024-10
    94/100 stars
      Buy from Supplier

    95
    Addgene inc pegfp c1 expression vectors
    PK-15 cells were transfected with <t>pEGFP-C1-wild-type</t> sPPARD (A), and -G32E mutant (B). G32E mutant was treated by leptomycin B (50 nM, 1 h) that blocked CRM1-dependent nuclear export (C). sPPARD subcellular localization was analyzed by GFP fluorescence at 24 hour post-transfection. Cell nuclei were counterstained with DAPI.
    Pegfp C1 Expression Vectors, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pegfp c1 expression vectors/product/Addgene inc
    Average 95 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pegfp c1 expression vectors - by Bioz Stars, 2024-10
    95/100 stars
      Buy from Supplier

    Image Search Results


    Representative photographs of monolayer differentiated cells (Days 2 and 7: original magnification, x200) (A). Representative electrophoretic mobility shift assays (EMSA) shows NF-κB binding activity in the undifferentiated iPS cells (FGF2+ and feeder+) and monolayer differentiated cells (FGF2- and feeder-). Proximal tubular epithelial cells (PTECs) were used as control cells (differentiated cells) for the EMSA. Results of 2 independent experiments are shown. In the last lane, the competition assays were performed using the undifferentiated iPS cells (B). Western blot analysis of actin, Oct3/4, NANOG, WT-1, and Pax-2 in the undifferentiated iPS cells (FGF2+ and feeder+) and monolayer differentiated cells (FGF2- and feeder-). Feeder cells (SNL) were used as negative control cells. Results of 2 independent experiments are shown (C).

    Journal: PLoS ONE

    Article Title: The Role of NF-κB Signaling in the Maintenance of Pluripotency of Human Induced Pluripotent Stem Cells

    doi: 10.1371/journal.pone.0056399

    Figure Lengend Snippet: Representative photographs of monolayer differentiated cells (Days 2 and 7: original magnification, x200) (A). Representative electrophoretic mobility shift assays (EMSA) shows NF-κB binding activity in the undifferentiated iPS cells (FGF2+ and feeder+) and monolayer differentiated cells (FGF2- and feeder-). Proximal tubular epithelial cells (PTECs) were used as control cells (differentiated cells) for the EMSA. Results of 2 independent experiments are shown. In the last lane, the competition assays were performed using the undifferentiated iPS cells (B). Western blot analysis of actin, Oct3/4, NANOG, WT-1, and Pax-2 in the undifferentiated iPS cells (FGF2+ and feeder+) and monolayer differentiated cells (FGF2- and feeder-). Feeder cells (SNL) were used as negative control cells. Results of 2 independent experiments are shown (C).

    Article Snippet: For the small interfering (si) RNA studies, designed and validated siRNA specific for NF-κB p65 (sc-29410), and control non-targeting siRNA (sc-37007) were purchased from Santa Cruz .

    Techniques: Electrophoretic Mobility Shift Assay, Binding Assay, Activity Assay, Western Blot, Negative Control

    Representative photomicrographs of human iPS cells: no treatment (A–D), treatment with control siRNA (E–H), treatment wirth p65 siRNA (I–L) (original magnification, x200). A representative EMSA shows NF-κB and AP-1 binding activity in human iPS cells treated with siRNA (M). Representative photographs of alkaline phosphatase staining of human iPS cells treated with siRNA (N–P) (original magnification, x200). No treatment (N), treatment with control siRNA (O), treatment with p65 siRNA (P).

    Journal: PLoS ONE

    Article Title: The Role of NF-κB Signaling in the Maintenance of Pluripotency of Human Induced Pluripotent Stem Cells

    doi: 10.1371/journal.pone.0056399

    Figure Lengend Snippet: Representative photomicrographs of human iPS cells: no treatment (A–D), treatment with control siRNA (E–H), treatment wirth p65 siRNA (I–L) (original magnification, x200). A representative EMSA shows NF-κB and AP-1 binding activity in human iPS cells treated with siRNA (M). Representative photographs of alkaline phosphatase staining of human iPS cells treated with siRNA (N–P) (original magnification, x200). No treatment (N), treatment with control siRNA (O), treatment with p65 siRNA (P).

    Article Snippet: For the small interfering (si) RNA studies, designed and validated siRNA specific for NF-κB p65 (sc-29410), and control non-targeting siRNA (sc-37007) were purchased from Santa Cruz .

    Techniques: Binding Assay, Activity Assay, Staining

    Western blot analysis of actin, NF-κB p65, IκBα, Oct3/4, Nanog, WT-1, and Pax-2 in human iPS cells treated with siRNA (A). Immunohistochemical staining for NF-κB p65 (B–D) and Oct3/4 (E–G) in human iPS cells treated with siRNA. No treatment (B and E), treatment with control siRNA (C and F), and treatment with p65 siRNA (D and G). Negative control staining without a primary antibody is shown (H) (Original magnification, x200).

    Journal: PLoS ONE

    Article Title: The Role of NF-κB Signaling in the Maintenance of Pluripotency of Human Induced Pluripotent Stem Cells

    doi: 10.1371/journal.pone.0056399

    Figure Lengend Snippet: Western blot analysis of actin, NF-κB p65, IκBα, Oct3/4, Nanog, WT-1, and Pax-2 in human iPS cells treated with siRNA (A). Immunohistochemical staining for NF-κB p65 (B–D) and Oct3/4 (E–G) in human iPS cells treated with siRNA. No treatment (B and E), treatment with control siRNA (C and F), and treatment with p65 siRNA (D and G). Negative control staining without a primary antibody is shown (H) (Original magnification, x200).

    Article Snippet: For the small interfering (si) RNA studies, designed and validated siRNA specific for NF-κB p65 (sc-29410), and control non-targeting siRNA (sc-37007) were purchased from Santa Cruz .

    Techniques: Western Blot, Immunohistochemical staining, Staining, Negative Control

    Effects of TPL and ATF on NF-κB and JNK signalling pathway. ( A ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. Nuclear proteins were extracted and subjected to Western blotting for p65 detection. Lamin B was used as loading control and α-tubulin was used as a cytoplasmic protein marker to rule out cytoplasmic contamination in the nuclear fraction. ( B ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. AKT, p-AKT, and c-FLIP proteins in whole cell lysates were determined with specific antibodies. GAPDH was used as loading control. ( C ) HCT116 cells were transfected with scramble siRNA or NF-κB p65 siRNA. 48 h later, cell extracts were applied for Western blotting analysis using NF-κB p65 and c-FLIP antibodies. ( D ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. c-JUN, p-c-JUN and p-JNK protein in whole cell lysates were determined with specific antibodies.

    Journal: Molecular Cancer

    Article Title: Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase

    doi: 10.1186/1476-4598-12-54

    Figure Lengend Snippet: Effects of TPL and ATF on NF-κB and JNK signalling pathway. ( A ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. Nuclear proteins were extracted and subjected to Western blotting for p65 detection. Lamin B was used as loading control and α-tubulin was used as a cytoplasmic protein marker to rule out cytoplasmic contamination in the nuclear fraction. ( B ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. AKT, p-AKT, and c-FLIP proteins in whole cell lysates were determined with specific antibodies. GAPDH was used as loading control. ( C ) HCT116 cells were transfected with scramble siRNA or NF-κB p65 siRNA. 48 h later, cell extracts were applied for Western blotting analysis using NF-κB p65 and c-FLIP antibodies. ( D ) HCT116 cells were treated with TPL and ATF alone or in combination for 24 h. c-JUN, p-c-JUN and p-JNK protein in whole cell lysates were determined with specific antibodies.

    Article Snippet: The siRNA against NF-κB p65 (sc-29410) was purchased from Santa Cruz Biotechnology, Santa Cruz, CA.

    Techniques: Western Blot, Marker, Transfection

    A working model for the synergistic effect of TPL and ATF on tumour cells. TPL and ATF cooperatively induce apoptosis through caspase-dependent pathway and cell cycle arrest. In HCT116 cells, combined treatment with TPL and ATF at a low dosage inhibits AKT phosphorylation and subsequently inactivates NF-κB. The inhibition of NF-κB leads to down-regulation of c-FLIP, activation of caspases-9/caspase-3 and JNK-c-JUN pathway, and cell cycle arrest, which finally promotes cell apoptosis. In addition, the suppression of NF-κB leads to decreased expression of uPAR, MMP-9 and phospho-FAK, thereby inhibiting tumor cell migration and invasion. Furthermore, ATF can segregate uPA from its receptor uPAR, thus blocking ECM remodeling and anti-angiogenesis processes.

    Journal: Molecular Cancer

    Article Title: Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase

    doi: 10.1186/1476-4598-12-54

    Figure Lengend Snippet: A working model for the synergistic effect of TPL and ATF on tumour cells. TPL and ATF cooperatively induce apoptosis through caspase-dependent pathway and cell cycle arrest. In HCT116 cells, combined treatment with TPL and ATF at a low dosage inhibits AKT phosphorylation and subsequently inactivates NF-κB. The inhibition of NF-κB leads to down-regulation of c-FLIP, activation of caspases-9/caspase-3 and JNK-c-JUN pathway, and cell cycle arrest, which finally promotes cell apoptosis. In addition, the suppression of NF-κB leads to decreased expression of uPAR, MMP-9 and phospho-FAK, thereby inhibiting tumor cell migration and invasion. Furthermore, ATF can segregate uPA from its receptor uPAR, thus blocking ECM remodeling and anti-angiogenesis processes.

    Article Snippet: The siRNA against NF-κB p65 (sc-29410) was purchased from Santa Cruz Biotechnology, Santa Cruz, CA.

    Techniques: Inhibition, Activation Assay, Expressing, Migration, Blocking Assay

    Increased expression of SNHG14 in LPS-induced HK-2 cells is due to the activation of the TLR4/NF- κ B pathway. (a) Expression level of SNHG14 in LPS-treated HK-2 cells. (b) Predicted binding site of NF- κ B in the SHNG14 promoter. (c) Activation of the TLR4/NF- κ B pathway in LPS-induced HK-2 cells. (d) ChIP assay showed NF- κ B bound to the SNHG14 promoter. (e) Luciferase assays showed that overexpressing NF- κ B p65 increased the activity of luciferase reporter containing a wild-type SNHG14 promoter. (f) SNHG14 levels in LPS-induced HK-2 cells transfected with NF- κ B p65 overexpression plasmids or shRNAs. Data were shown as mean ± SD, ∗ P < 0.05.

    Journal: Mediators of Inflammation

    Article Title: lncRNA SNHG14 Plays a Role in Sepsis-Induced Acute Kidney Injury by Regulating miR-93

    doi: 10.1155/2021/5318369

    Figure Lengend Snippet: Increased expression of SNHG14 in LPS-induced HK-2 cells is due to the activation of the TLR4/NF- κ B pathway. (a) Expression level of SNHG14 in LPS-treated HK-2 cells. (b) Predicted binding site of NF- κ B in the SHNG14 promoter. (c) Activation of the TLR4/NF- κ B pathway in LPS-induced HK-2 cells. (d) ChIP assay showed NF- κ B bound to the SNHG14 promoter. (e) Luciferase assays showed that overexpressing NF- κ B p65 increased the activity of luciferase reporter containing a wild-type SNHG14 promoter. (f) SNHG14 levels in LPS-induced HK-2 cells transfected with NF- κ B p65 overexpression plasmids or shRNAs. Data were shown as mean ± SD, ∗ P < 0.05.

    Article Snippet: PcDNA3.1-SNHG14 overexpression (O/E) plasmids, SNHG14 shRNA, pcDNA3.1-NF- κ B p65 O/E plasmids, NF- κ B p65 shRNA (sc-29410-SH, Santa Cruz Biotechnology), miR-93 mimics, and miR-93 inhibitor were transfected into cells using Lipofectamine 3000 (Invitrogen, CA, USA).

    Techniques: Expressing, Activation Assay, Binding Assay, Luciferase, Activity Assay, Transfection, Over Expression

    SNHG14/miR-93 activates NF- κ B and STAT3 signaling through mediating IRAK4 and IL-6R. (a) Predicted binding site of miR-93 in IRAK4 and IL-6R 3′UTR. (b, c) Luciferase assays showed that overexpressing miR-93 decreased the activity of luciferase reporter containing wild-type IRAK4 or IL-6R 3′UTR. (d) IRAK4 and IL-6R protein levels detected by western blot after HK-2 cells were transfected with miR-93 mimics or inhibitor. (e, f) HK-2 cells were transfected with SNHG14 overexpression plasmids and miR-93 mimics, and LPS-induced HK-2 cells were transfected with SNHG14 shRNAs and miR-93 inhibitor; relative proteins in IRAK4/NF-kb and IL-6R/STAT3 signaling were analyzed using western blot. Data were shown as mean ± SD, ∗ P < 0.05.

    Journal: Mediators of Inflammation

    Article Title: lncRNA SNHG14 Plays a Role in Sepsis-Induced Acute Kidney Injury by Regulating miR-93

    doi: 10.1155/2021/5318369

    Figure Lengend Snippet: SNHG14/miR-93 activates NF- κ B and STAT3 signaling through mediating IRAK4 and IL-6R. (a) Predicted binding site of miR-93 in IRAK4 and IL-6R 3′UTR. (b, c) Luciferase assays showed that overexpressing miR-93 decreased the activity of luciferase reporter containing wild-type IRAK4 or IL-6R 3′UTR. (d) IRAK4 and IL-6R protein levels detected by western blot after HK-2 cells were transfected with miR-93 mimics or inhibitor. (e, f) HK-2 cells were transfected with SNHG14 overexpression plasmids and miR-93 mimics, and LPS-induced HK-2 cells were transfected with SNHG14 shRNAs and miR-93 inhibitor; relative proteins in IRAK4/NF-kb and IL-6R/STAT3 signaling were analyzed using western blot. Data were shown as mean ± SD, ∗ P < 0.05.

    Article Snippet: PcDNA3.1-SNHG14 overexpression (O/E) plasmids, SNHG14 shRNA, pcDNA3.1-NF- κ B p65 O/E plasmids, NF- κ B p65 shRNA (sc-29410-SH, Santa Cruz Biotechnology), miR-93 mimics, and miR-93 inhibitor were transfected into cells using Lipofectamine 3000 (Invitrogen, CA, USA).

    Techniques: Binding Assay, Luciferase, Activity Assay, Western Blot, Transfection, Over Expression

    Silencing SNHG14 alleviates the cellular injury process of IL-1 β and IL-6 in HK-2 cells via miR-93. (a–n) HK-2 cells were treated with IL-1 β or IL-6 and then transfected with SNHG14 shRNAs and miR-93 inhibitor; oxidative stress (a–d), inflammation (e–h), and apoptosis (i–l) were assessed as described above; activation of NF- κ B and STAT3 signaling was tested by detecting relative proteins using western blot (m, n). Data were shown as mean ± SD, ∗ P < 0.05.

    Journal: Mediators of Inflammation

    Article Title: lncRNA SNHG14 Plays a Role in Sepsis-Induced Acute Kidney Injury by Regulating miR-93

    doi: 10.1155/2021/5318369

    Figure Lengend Snippet: Silencing SNHG14 alleviates the cellular injury process of IL-1 β and IL-6 in HK-2 cells via miR-93. (a–n) HK-2 cells were treated with IL-1 β or IL-6 and then transfected with SNHG14 shRNAs and miR-93 inhibitor; oxidative stress (a–d), inflammation (e–h), and apoptosis (i–l) were assessed as described above; activation of NF- κ B and STAT3 signaling was tested by detecting relative proteins using western blot (m, n). Data were shown as mean ± SD, ∗ P < 0.05.

    Article Snippet: PcDNA3.1-SNHG14 overexpression (O/E) plasmids, SNHG14 shRNA, pcDNA3.1-NF- κ B p65 O/E plasmids, NF- κ B p65 shRNA (sc-29410-SH, Santa Cruz Biotechnology), miR-93 mimics, and miR-93 inhibitor were transfected into cells using Lipofectamine 3000 (Invitrogen, CA, USA).

    Techniques: Transfection, Activation Assay, Western Blot

    Effect of TPL on NF-κB activity and NF-κB p65 expression inMHCC-97H cell. ( A ) MHCC-97H cells were treated with 5, 15,or 25 μM TPL for 72 hours. Nuclear extracts were prepared from control and treated cells and subjected to analysis for NF-κB DNA-binding activity as measured by EMSA. ( B ) MHCC-97H cells were treated with 25 μM TPL for 24–60 hours. Nuclear extracts were prepared from control and treated cells and subjected to analysis for NF-κB DNA-binding activity as measured by EMSA. ( C ) MHCC-97H cells were treated with 5, 15, or 25 μM TPL for 72 hours. NF-κB p65 protein was detected by western blot assay; ( D ) MHCC-97H cells were treated with 25 μM TPL for 24–60 hours. NF-κB p65 protein was detected by western blot assay.

    Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

    Article Title: Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling

    doi: 10.12659/MSM.898801

    Figure Lengend Snippet: Effect of TPL on NF-κB activity and NF-κB p65 expression inMHCC-97H cell. ( A ) MHCC-97H cells were treated with 5, 15,or 25 μM TPL for 72 hours. Nuclear extracts were prepared from control and treated cells and subjected to analysis for NF-κB DNA-binding activity as measured by EMSA. ( B ) MHCC-97H cells were treated with 25 μM TPL for 24–60 hours. Nuclear extracts were prepared from control and treated cells and subjected to analysis for NF-κB DNA-binding activity as measured by EMSA. ( C ) MHCC-97H cells were treated with 5, 15, or 25 μM TPL for 72 hours. NF-κB p65 protein was detected by western blot assay; ( D ) MHCC-97H cells were treated with 25 μM TPL for 24–60 hours. NF-κB p65 protein was detected by western blot assay.

    Article Snippet: NF-κB p65 siRNA was purchased from Santa Cruz Biotechnology (Santa Cruz, Shanghai, China).

    Techniques: Activity Assay, Expressing, Binding Assay, Western Blot

    TPL induces apoptosis by inhibition of NF-κB activity.( A ) The effect of p65 cDNA transfection and TPL treatment on NF-κB DNA-binding activity by EMSA assay. ( B ) Induction of apoptosis by p65 cDNA and TPL in MHCC-97H cells tested by flow cytometry. ( C ) Induction of apoptosis by p65 cDNA and TPL in MHCC-97H cells tested by TUNEL assay. ( D ) the effect of p65 siRNA transfection and TPL on NF-κB DNA-binding activity by EMSA assay. ( E ) Induction of apoptosis by p65 siRNA and TPL in MHCC-97H cells tested by flow cytometry. ( F ) Induction of apoptosis by p65 siRNA and TPL in MHCC-97H cells tested by TUNEL assay. Values are reported as mean ±SD. p <0.05, compared to the control.

    Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

    Article Title: Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling

    doi: 10.12659/MSM.898801

    Figure Lengend Snippet: TPL induces apoptosis by inhibition of NF-κB activity.( A ) The effect of p65 cDNA transfection and TPL treatment on NF-κB DNA-binding activity by EMSA assay. ( B ) Induction of apoptosis by p65 cDNA and TPL in MHCC-97H cells tested by flow cytometry. ( C ) Induction of apoptosis by p65 cDNA and TPL in MHCC-97H cells tested by TUNEL assay. ( D ) the effect of p65 siRNA transfection and TPL on NF-κB DNA-binding activity by EMSA assay. ( E ) Induction of apoptosis by p65 siRNA and TPL in MHCC-97H cells tested by flow cytometry. ( F ) Induction of apoptosis by p65 siRNA and TPL in MHCC-97H cells tested by TUNEL assay. Values are reported as mean ±SD. p <0.05, compared to the control.

    Article Snippet: NF-κB p65 siRNA was purchased from Santa Cruz Biotechnology (Santa Cruz, Shanghai, China).

    Techniques: Inhibition, Activity Assay, Transfection, Binding Assay, Flow Cytometry, TUNEL Assay

    TPL inhibits tumor growth and the expression of NF-κB target genes in vivo . MHCC-97H xenografts were generated by inoculating cells subcutaneously (s.c.) in SCID mice. Once transplanted, the cells developed into palpable tumors (about 80 mg), and groups of 10 animals were classified randomly and assigned to different treatment groups. Mice were injected with TPL at 0.4 mg/kg daily for 15 days. The control group received vehicle only. ( A ) TPL retards the growth of MHCC-97H tumor xenografts in nude mice. Tumor volumes in SCID mice were plotted against time; * p <0.05, compared to the control. ( B ) The number of metastatic nodes in each group. Lung tumors were counted with the naked eye. The data represent the mean and the standard deviation (n=10). p values were calculated with the Student’s t-test. * p <0.05. Black is a metastatic node. ( C ) TPL inhibits NF-κB DNA-binding activity in vivo . Tumor xenografts were removed, and nuclear protein extracts were prepared. Binding of NF-κB consensus elements with nuclear extracts was detected by EMSA. ( D ) The expression of NF-κB p65 and MMP-9 was detected by western blotting of tumor tissue extracts. TPL inhibited the expression of NF-κB p65 and MMP-9 in tumor tissues of TPL treated animals compared to controls.

    Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

    Article Title: Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling

    doi: 10.12659/MSM.898801

    Figure Lengend Snippet: TPL inhibits tumor growth and the expression of NF-κB target genes in vivo . MHCC-97H xenografts were generated by inoculating cells subcutaneously (s.c.) in SCID mice. Once transplanted, the cells developed into palpable tumors (about 80 mg), and groups of 10 animals were classified randomly and assigned to different treatment groups. Mice were injected with TPL at 0.4 mg/kg daily for 15 days. The control group received vehicle only. ( A ) TPL retards the growth of MHCC-97H tumor xenografts in nude mice. Tumor volumes in SCID mice were plotted against time; * p <0.05, compared to the control. ( B ) The number of metastatic nodes in each group. Lung tumors were counted with the naked eye. The data represent the mean and the standard deviation (n=10). p values were calculated with the Student’s t-test. * p <0.05. Black is a metastatic node. ( C ) TPL inhibits NF-κB DNA-binding activity in vivo . Tumor xenografts were removed, and nuclear protein extracts were prepared. Binding of NF-κB consensus elements with nuclear extracts was detected by EMSA. ( D ) The expression of NF-κB p65 and MMP-9 was detected by western blotting of tumor tissue extracts. TPL inhibited the expression of NF-κB p65 and MMP-9 in tumor tissues of TPL treated animals compared to controls.

    Article Snippet: NF-κB p65 siRNA was purchased from Santa Cruz Biotechnology (Santa Cruz, Shanghai, China).

    Techniques: Expressing, In Vivo, Generated, Injection, Standard Deviation, Binding Assay, Activity Assay, Western Blot

    PK-15 cells were transfected with pEGFP-C1-wild-type sPPARD (A), and -G32E mutant (B). G32E mutant was treated by leptomycin B (50 nM, 1 h) that blocked CRM1-dependent nuclear export (C). sPPARD subcellular localization was analyzed by GFP fluorescence at 24 hour post-transfection. Cell nuclei were counterstained with DAPI.

    Journal: PLoS ONE

    Article Title: The G32E Functional Variant Reduces Activity of PPARD by Nuclear Export and Post-Translational Modification in Pigs

    doi: 10.1371/journal.pone.0075925

    Figure Lengend Snippet: PK-15 cells were transfected with pEGFP-C1-wild-type sPPARD (A), and -G32E mutant (B). G32E mutant was treated by leptomycin B (50 nM, 1 h) that blocked CRM1-dependent nuclear export (C). sPPARD subcellular localization was analyzed by GFP fluorescence at 24 hour post-transfection. Cell nuclei were counterstained with DAPI.

    Article Snippet: Wild-type sPPARD and G32E mutant were cloned into pEGFP-C1 expression vectors (Addgene), and wild-type sPPARD, G32E, K16R, K17R, K18R and K16-18R mutants were inserted into pcDNA4A-His expression vectors (Addgene).

    Techniques: Transfection, Mutagenesis, Fluorescence